Cited by 204Nitric Oxide and Endothelin EffectsRenin-Angiotensin System StudiesEicosanoids and Hypertension Pharmacology

Role of Extracellular Superoxide Dismutase in Hypertension

Gongora, Maria Carolina, Qin, Zhenyu, Laude, Karine, Kim, Ha Won, McCann, Louise, Folz, J. Rodney, Dikalov, Sergey, Fukai, Tohru +1 more·2006·Hypertension

Abstract

We previously found that angiotensin II–induced hypertension increases vascular extracellular superoxide dismutase (ecSOD), and proposed that this is a compensatory mechanism that blunts the hypertensive response and preserves endothelium-dependent vasodilatation. To test this hypothesis, we studied ecSOD-deficient mice. ecSOD −/− and C57Blk/6 mice had similar blood pressure at baseline; however, the hypertension caused by angiotensin II was greater in ecSOD −/− compared with wild-type mice (168 versus 147 mm Hg, respectively; P <0.01). In keeping with this, angiotensin II increased superoxide and reduced endothelium-dependent vasodilatation in small mesenteric arterioles to a greater extent in ecSOD −/− than in wild-type mice. In contrast to these findings in resistance vessels, angiotensin II paradoxically improved endothelium-dependent vasodilatation, reduced intracellular and extracellular superoxide, and increased NO production in aortas of ecSOD −/− mice. Whereas aortic expression of endothelial NO synthase, Cu/ZnSOD, and MnSOD were not altered in ecSOD −/− mice, the activity of Cu/ZnSOD was increased by 80% after angiotensin II infusion. This was associated with a concomitant increase in expression of the copper chaperone for Cu/ZnSOD in the aorta but not in the mesenteric arteries. Moreover, the angiotensin II–induced increase in aortic reduced nicotinamide-adenine dinucleotide phosphate oxidase activity was diminished in ecSOD −/− mice as compared with controls. Thus, during angiotensin II infusion, ecSOD reduces hypertension, minimizes vascular superoxide production, and preserves endothelial function in resistance arterioles. We also identified novel compensatory mechanisms involving upregulation of copper chaperone for Cu/ZnSOD, increased Cu/ZnSOD activity, and decreased reduced nicotinamide-adenine dinucleotide phosphate oxidase activity in larger vessels. These compensatory mechanisms preserve large vessel function when ecSOD is absent in hypertension.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.hyp.0000235682.47673.ab

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Endothelial dysfunction, characterized by a lack of dilation of blood vessels in response to endothelium-dependent vasoactive substances such as acetylcholine, is consistent with a deficiency of bioavailable nitric oxide.

    “Endothelial dysfunction, characterized by a lack of dilation of blood vessels in response to endothelium-dependent vasoactive substances, such as acetylcholine, is consistent with a deficiency of bioavailable NO· (158, 200, 266).”

    From Redox regulation of mitochondrial function (2012) · cites this paper as [158]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 31 · Cited by 204

Authors
Gongora, M. C., Qin, Z., Laude, K., Kim, H. W., McCann, L., Folz, J. R., Dikalov, S., Fukai, T., & Harrison, D. G.
Affiliations
  • From the Department of Medicine (M.C.G., Z.Q., H.W.K., L.M., S.D., T.F., D.G.H.), Division of Cardiology, Emory University School of Medicine, Atlanta, Ga; Forenap-Pharma (K.L.), Ch-Rouffach, France; and the Department of Medicine (J.R.F.), Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University Medical Center, Durham, NC.
  • Emory University (US)
Venue
Hypertension
Published
2006-09
Volume
48
Issue
3
Pages
473-481
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2171170747
Cited by
204
References
31
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 11 · 2021: 5 · 2020: 5 · 2019: 10 · 2018: 11 · 2017: 8 · 2016: 11 · 2015: 8 · 2014: 13 · 2013: 19 · 2012: 22
FWCI
9.94
Type
journal article
Language
en
Open access
closed
Locations
  • Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Veterans Affairs
  • National Institutes of Health (5p01hl075209-05, 5r01hl059248-04)
  • National Heart, Lung, and Blood Institute (HL 58000, HL 59248, HL38206, R01HL039006, HL-075209, HL70187, P01HL058000, HL-39006, R01HL070187)
Topics
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords
extracellular superoxide dismutase, angiotensin II-induced hypertension, endothelium-dependent vasodilatation, superoxide, endothelial function, resistance arterioles, mesenteric arteries, aorta, endothelial nitric oxide synthase, copper-zinc superoxide dismutase, NADPH oxidase, NO production
MeSH terms
NADPH Oxidase 1, Angiotensin II, Animals, Aorta, Blood Pressure, Hypertension, Isoenzymes, Mesenteric Arteries, Mice, Inbred C57BL, NADH, NADPH Oxidoreductases, Nitric Oxide, Superoxides, Superoxide Dismutase, Vasoconstrictor Agents, Vasodilation, Vasomotor System, Mice, Knockout, NADPH Oxidases, Mice, Nitric Oxide Synthase Type III

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review